Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

  BIOTECHNOLOGY EUROPE NEWS    

 

 

 
 

 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

post your news I subscribe newsletter I contact us

30.04.2008 Rockeby Partners with Novartis China subsidiary to launch Pepp® in China

 

30.04.2008 SomnoMed accelerate third quarter global unit sales

 

29.04.2008 Ulf Wiinberg appointed new CEO of Lundbeck

 

29.04.2008 Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus

 

29.04.2008 Antisoma Interim Management Statement

 

29.04.2008 Benitec secures further rights to HIV Therapeutic

 

28.04.2008 NuSep Interest Bearing 14% Converting Notes

 

24.04.2008 Solvay Pharmaceuticals S.A. Launches Friendly Bid to Acquire Innogenetics

 

24.04.2008 Interim Report January-March 2008 Tripep AB (publ)

 

24.04.2008 Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent to $1.12

 

24.04.2008 GenOway  signs a major master services agreement with the Japanese pharmaceutical leader Eisai Co., Ltd.

 

23.04.2008 Active Biotech AB Interim Report January-March 2008

 

23.04.2008 Bard Announces First Quarter Results

 

23.04.2008 New incentive plan in the Lundbeck Group

 

23.04.2008 Q1/2008: Merck Operating Result Increases 49% to € 360 Million

 

21.04.2008 RidePharm and 4Vision form Alliance to expand their consulting excellence in the Pharma and Biotech industry.

 

20.04.2008 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer